BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Chapter

Reset

Active filters

Chemical substance: Carvedilol

Presentation	Product	Chemical substance	Chapter	Items dispensed
Carvedilol 6.25mg tablets 020400080AAAFAF	Carvedilol	Carvedilol	Cardiovascular System	59,156
Carvedilol 3.125mg tablets 020400080AAAEAE	Carvedilol	Carvedilol	Cardiovascular System	49,417
Carvedilol 12.5mg tablets 020400080AAABAB	Carvedilol	Carvedilol	Cardiovascular System	43,133
Carvedilol 25mg tablets 020400080AAACAC	Carvedilol	Carvedilol	Cardiovascular System	31,997
Carvedilol 5mg/5ml oral suspension 020400080AAAPAP	Carvedilol	Carvedilol	Cardiovascular System	377
Carvedilol 1.5mg/5ml oral suspension 020400080AAAMAM	Carvedilol	Carvedilol	Cardiovascular System	No data available
Carvedilol 3.125mg/5ml oral suspension 020400080AAADAD	Carvedilol	Carvedilol	Cardiovascular System	No data available
Carvedilol 3.5mg suppositories 020400080AAANAN	Carvedilol	Carvedilol	Cardiovascular System	No data available
Eucardic 12.5mg tablets 020400080BBAAAB	Eucardic	Carvedilol	Cardiovascular System	No data available
Eucardic 25mg tablets 020400080BBABAC	Eucardic	Carvedilol	Cardiovascular System	No data available
Eucardic 3.125mg tablets 020400080BBACAE	Eucardic	Carvedilol	Cardiovascular System	No data available
Eucardic 6.25mg tablets 020400080BBADAF	Eucardic	Carvedilol	Cardiovascular System	No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.